retatrutide ly3437943 glp-1 gip glucagon receptor agonist 𧬠R3TA is a next-generation peptide being studied for its unique triple- approach to metabolic health. Unlike traditional therapies, R3TA is designed to interact with three metabolic pathways simultaneously: GLP-1, Retatrutide, a GIP, GLP-1 and
Pay in 4 interest-free payments of $5.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Sep 28 - Oct 3
01053-X/asset/68ad1d8b-bb7e-4ca0-8f89-99384d885ca3/main.assets/gr2.jpg)











02105-1/asset/8468e457-0c7f-4e4c-9b6d-2202dbefa9cb/main.assets/gr1_lrg.jpg)













